IL138624A0 - Nucleic acid transfer vectors, compositions containing same and uses - Google Patents
Nucleic acid transfer vectors, compositions containing same and usesInfo
- Publication number
- IL138624A0 IL138624A0 IL13862499A IL13862499A IL138624A0 IL 138624 A0 IL138624 A0 IL 138624A0 IL 13862499 A IL13862499 A IL 13862499A IL 13862499 A IL13862499 A IL 13862499A IL 138624 A0 IL138624 A0 IL 138624A0
- Authority
- IL
- Israel
- Prior art keywords
- nucleic acid
- compositions containing
- transfer vectors
- containing same
- acid transfer
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 239000013598 vector Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
- A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9803573A FR2776669B1 (en) | 1998-03-24 | 1998-03-24 | NUCLEIC ACID TRANSFER VECTORS, COMPOSITIONS CONTAINING SAME, AND USES THEREOF |
| US8584898P | 1998-05-18 | 1998-05-18 | |
| PCT/FR1999/000643 WO1999049067A1 (en) | 1998-03-24 | 1999-03-19 | Nucleic acid transfer vectors, compositions containing same and uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL138624A0 true IL138624A0 (en) | 2001-10-31 |
Family
ID=26234216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13862499A IL138624A0 (en) | 1998-03-24 | 1999-03-19 | Nucleic acid transfer vectors, compositions containing same and uses |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1066396A1 (en) |
| JP (1) | JP2002507429A (en) |
| KR (1) | KR20010074456A (en) |
| CN (1) | CN1292827A (en) |
| AU (1) | AU758406B2 (en) |
| BR (1) | BR9909044A (en) |
| CA (1) | CA2323831A1 (en) |
| HU (1) | HUP0102413A3 (en) |
| IL (1) | IL138624A0 (en) |
| NO (1) | NO20004648L (en) |
| PL (1) | PL342944A1 (en) |
| WO (1) | WO1999049067A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ522860A (en) | 2000-05-26 | 2004-09-24 | Gencell S | Purification of a triple helix formation with an immobilized oligonucleotide |
| FR2871465B1 (en) * | 2004-06-15 | 2006-09-08 | Centre Nat Rech Scient Cnrse | COLLECTIONS OF TRACEABLE COMPOUNDS AND USES THEREOF |
| US7943589B2 (en) | 2005-06-03 | 2011-05-17 | President And Fellows Of Harvard College | siRNA microbicides for preventing and treating diseases |
| US7795380B2 (en) | 2006-06-02 | 2010-09-14 | University Of Iowa Research Foundation | Compositions and methods for nucleic acid delivery |
| WO2017156038A2 (en) * | 2016-03-07 | 2017-09-14 | Alere San Diego, Inc. | Immunoassay controls and the use thereof |
| RU2731513C2 (en) * | 2018-12-21 | 2020-09-03 | Селл энд Джин Терапи Лтд | Gene-therapeutic dna-vector based on gene-therapeutic dna-vector vtvaf17, carrying target gene selected from group of genes nos2, nos3, vip, kcnma1, cgrp, to increase expression level of these target genes, method for production and use thereof, strain escherichia coli scs110-af/vtvaf17-nos2, or escherichia coli scs110-af/vtvaf17-nos3, or escherichia coli scs110-af/vtvaf17-vip, or escherichia coli scs110-af/vtvaf17-kcnma1, or escherichia coli scs110-af/vtvaf17-cgrp, carrying gene-therapeutic dna vector, method for production thereof, method for industrial production of gene-therapeutic dna vector |
| WO2024206118A1 (en) * | 2023-03-24 | 2024-10-03 | Yarrow Therapeutics, Inc. | Nuclear localization polypeptides and conjugates and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2028792A (en) * | 1991-05-17 | 1992-12-30 | Uab Research Foundation | Sequence specific dna binding drugs |
| US5670347A (en) * | 1994-05-11 | 1997-09-23 | Amba Biosciences Llc | Peptide-mediated gene transfer |
| FR2731014B1 (en) * | 1995-02-23 | 1997-03-28 | Rhone Poulenc Rorer Sa | DNA MOLECULES, PREPARATION AND USE IN GENE THERAPY |
-
1999
- 1999-03-19 HU HU0102413A patent/HUP0102413A3/en unknown
- 1999-03-19 CN CN998039314A patent/CN1292827A/en active Pending
- 1999-03-19 CA CA002323831A patent/CA2323831A1/en not_active Abandoned
- 1999-03-19 PL PL99342944A patent/PL342944A1/en not_active Application Discontinuation
- 1999-03-19 IL IL13862499A patent/IL138624A0/en unknown
- 1999-03-19 WO PCT/FR1999/000643 patent/WO1999049067A1/en not_active Ceased
- 1999-03-19 JP JP2000538027A patent/JP2002507429A/en not_active Withdrawn
- 1999-03-19 KR KR1020007010485A patent/KR20010074456A/en not_active Ceased
- 1999-03-19 BR BR9909044-9A patent/BR9909044A/en not_active IP Right Cessation
- 1999-03-19 EP EP99910417A patent/EP1066396A1/en not_active Withdrawn
-
2000
- 2000-05-12 AU AU34062/00A patent/AU758406B2/en not_active Ceased
- 2000-09-18 NO NO20004648A patent/NO20004648L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL342944A1 (en) | 2001-07-16 |
| CA2323831A1 (en) | 1999-09-30 |
| HUP0102413A1 (en) | 2001-10-28 |
| CN1292827A (en) | 2001-04-25 |
| AU758406B2 (en) | 2003-03-20 |
| WO1999049067A1 (en) | 1999-09-30 |
| EP1066396A1 (en) | 2001-01-10 |
| BR9909044A (en) | 2000-12-05 |
| HUP0102413A3 (en) | 2003-09-29 |
| JP2002507429A (en) | 2002-03-12 |
| KR20010074456A (en) | 2001-08-04 |
| NO20004648D0 (en) | 2000-09-18 |
| AU3406200A (en) | 2000-12-14 |
| NO20004648L (en) | 2000-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL342081A1 (en) | Novel quaternary ammonia compounds, compositions containing them and their application | |
| GB2361904B (en) | Transfer system | |
| AU4289399A (en) | Nucleic acid transfer phage | |
| IL162274A (en) | Nucleic acid and protein designated 193p1e1b and compositions containing the same | |
| PL339920A1 (en) | Synergetic compositions comprising oxathiazine and benzothiophene-2-carboxamido-s,s-dioxide | |
| IL130608A0 (en) | Novel nucleic and amino acid sequence | |
| IL138624A0 (en) | Nucleic acid transfer vectors, compositions containing same and uses | |
| IL148805A0 (en) | Gene transfer vectors | |
| GB9717932D0 (en) | Estimation of nucleic acid | |
| HUP0200345A3 (en) | Novel nucleic acid transferring agents, compositions containing them and uses | |
| HUP0102455A3 (en) | Novel nucleic acid transfer agents, compositions containing same and uses | |
| GB9817909D0 (en) | DNA constructs | |
| AU1728197A (en) | Lipopolyamine compound, pharmaceutical composition and nucleic acid transfer vector containing same, and preparation method | |
| GB9917875D0 (en) | Nucleic acid constructs | |
| ZA992262B (en) | Vectors for transferring nucleic acids, compositions containing them and their uses. | |
| AU4513599A (en) | Nucleotide sequence | |
| HUP0003585A3 (en) | Gene coding for androctonine, vector containing same and transformed disease-resistant plants obtained | |
| AU7790300A (en) | Cd29 pig protein, nucleic acid coding for said protein and the applications thereof | |
| EP1067140A4 (en) | Novel hemolytic active proteins and genes encoding the same | |
| GB9822490D0 (en) | Nucleic acid | |
| GB9823481D0 (en) | Nucleic acid | |
| IL142278A0 (en) | Imidazo-isoquinoline compounds, their compositions and uses | |
| AUPP704498A0 (en) | Nucleic acid sequence | |
| HUP0101911A3 (en) | Novel sequence class of genes, corresponding proteins and the use of the same | |
| GB9701886D0 (en) | Nucleic acid |